Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I Robinson

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Molecular Therapy. Oncology|November 14, 2025
Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcomaSteven I Robinson, Susan M Clark, Ianko D Iankov, et al.
Rare Tumors|August 13, 2015
Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing SarcomaSteven Attia, Scott H Okuno, Steven I Robinson, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2021
Musculoskeletal Oncologic Interventions: Proceedings from the Society of Interventional Radiology and Society of Interventional Oncology Research Consensus PanelAnil Nicholas Kurup, Jack W Jennings, Sean Tutton, et al.
Cancers|November 27, 2025
Staged Reconstruction Is Not Necessary Following Oncologic Resection of Superficial MyxofibrosarcomaLeilani Garayua-Cruz, Samuel E Broida, Mikaela H Sullivan, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing SarcomaShuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Oncotarget|April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to deliveryAlan H Bryce, Jan B Egan, Mitesh J Borad, et al.
JCO Precision Oncology|February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in CholangiocarcinomaJan B Egan, David L Marks, Tara L Hogenson, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Molecular Therapy. Oncology|November 14, 2025
Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcomaSteven I Robinson, Susan M Clark, Ianko D Iankov, et al.
Rare Tumors|August 13, 2015
Clinical Activity of Pazopanib in Metastatic Extraosseous Ewing SarcomaSteven Attia, Scott H Okuno, Steven I Robinson, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2021
Musculoskeletal Oncologic Interventions: Proceedings from the Society of Interventional Radiology and Society of Interventional Oncology Research Consensus PanelAnil Nicholas Kurup, Jack W Jennings, Sean Tutton, et al.
Cancers|November 27, 2025
Staged Reconstruction Is Not Necessary Following Oncologic Resection of Superficial MyxofibrosarcomaLeilani Garayua-Cruz, Samuel E Broida, Mikaela H Sullivan, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
Disruption of Microhomology-mediated End-joining in Ewing SarcomaShuhei Asada, Guangli Zhu, Jithma Prasad Abeykoon, et al.
Nature Communications|January 12, 2024
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trialEvanthia Galanis, Katharine E Dooley, S Keith Anderson, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Oncotarget|April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to deliveryAlan H Bryce, Jan B Egan, Mitesh J Borad, et al.
JCO Precision Oncology|February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in CholangiocarcinomaJan B Egan, David L Marks, Tara L Hogenson, et al.
Journal of Translational Medicine|June 23, 2023
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)Filippo Pinto E Vairo, Jennifer L Kemppainen, Carolyn R Rohrer Vitek, et al.
Pageof 5